Safety and Tolerability of TOP-N53 Applied on Digital Ulcers in Patients With Systemic Sclerosis

NCT06954597 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
15
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Topadur Pharma AG

Collaborators